Source: Virtual Congress 2020 – ALERT: Pneumothorax, cough, PAH, alveolar proteinosis



Rating:

Share or cite this content

Citations should be made in the following way:
L. McGarvey (Belfast, United Kingdom), S. Birring (London, United Kingdom), A. Morice (Cottingham, United Kingdom), P. Dicpinigaitis (New York, United States of America), I. Pavord (Oxford, United Kingdom), J. Schelfhout (Kenilworth, United States of America), A. Martin Nguyen (Kenilworth, United States of America), Q. Li (Kenilworth, United States of America), A. Tzontcheva (Kenilworth, United States of America), B. Iskold (Kenilworth, United States of America), S. Green (Kenilworth, United States of America), C. La Rosa (Kenilworth, United States of America), D. Muccino (Kenilworth, United States of America), J. Smith (Manchester, United Kingdom). Late Breaking Abstract - Two Phase 3 Randomized Clinical Trials of Gefapixant, a P2X3 Receptor Antagonist, in Refractory or Unexplained Chronic Cough (COUGH-1 and COUGH-2). 3800

Member's Comments

No comment yet.

Related content which might interest you: The Effect of MK-7264, a P2X3 antagonist, on Cough Reflex Sensitivity in a Randomized Crossover Trial of Healthy and Chronic Cough Subjects Source: International Congress 2017 – New ideas for the management of chronic lung diseases Year: 2017 Late Breaking Abstract - Bronchial Rheoplasty For Treatment of Chronic Bronchitis: 6 Month Results from a Prospective Multi-Center Study Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough Year: 2019 LATE-BREAKING ABSTRACT: TITLE: Hypertonic Saline in Acute Bronchiolitis: Randomised Controlled Trial (RCT) and Economic Evaluation (The SABRE Study) Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children Year: 2014 Late Breaking Abstract - Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT) Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Curcumin Improves Therapy of Moderate Partially Controlled Asthma: Placebo-controlled, single blind study Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019 Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Late Breaking Abstract - BBT-877, a Potent Autotaxin Inhibitor in Clinical Development to Treat Idiopathic Pulmonary Fibrosis Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 Late Breaking Abstract - Prone-Positioning in Awake, Non-Intubated Patients with COVID-19 Hypoxemic Failure: A Single-Center Trial Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term Year: 2021 Late Breaking Abstract - First-in-Human Results of Bronchial Rheoplasty: An Endobronchial Treatment For Chronic Bronchitis (CB) Source: International Congress 2018 – Interventional pulmonology highlights in 2018: latest innovations Year: 2018 Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study. Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Late Breaking Abstract - Abdominal Muscle Function During Spontaneous Breathing Trials to Predict Extubation Failure Source: Virtual Congress 2020 – Novel findings regarding acute respiratory distress syndrome, extra corporeal membrane oxygenation and weaning from mechanical ventilation Year: 2020 Long-Acting Beta Agonist Asthma Pharmacogenetic Loci Identified in Two Multi-Racial Asthma Clinical Trials Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Home Noninvasive Ventilation with Built-in Software in Chronic Hypercapnic COPD Patients: a Mid-term Prospective, Multicenter, Randomized, Controlled Trial Source: International Congress 2018 – New insights in the management of chronic respiratory failure Year: 2018 Comparison of Clinical Efficacy and Safety between ultraLABAs and ultraLAMAs in Patients with COPD: A Systemic Review with a Meta-Analysis of Randomized Controlled Trials Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 Late Breaking Abstract - Comparative Effectiveness of Anti-IL5/5R Versus Anti-IgE in Patients Eligible for Both (FIRE) Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Late Breaking Abstract - Clinical Efficacy and Safety of Macitentan Transitioned from Bosentan in Patients with Pulmonary Arterial Hypertension Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Late Breaking Abstract - Endobronchial Valves for Severe Emphysema – 12-month Results of the EMPROVE Trial Source: International Congress 2018 – Interventional pulmonology highlights in 2018: ELVR, TLD and BT Year: 2018 Late Breaking Abstract - SUPRAnav: A Clinical Trial Evaluating the Efficacy and Safety of a New Invention Device Designed for Continuous Supraglottic Aspiration in Mechanically Ventilated Patients. Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Intensive care and infection Year: 2019 Late Breaking Abstract - Effects of long-term Tobramycin Inhalation Solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. The BATTLE Randomized Controlled Trial Source: Virtual Congress 2020 – ALERT: Infection in adults and children Year: 2020 Late Breaking Abstract - Blood Eosinophils as Predictor of Outcomes in hospitalized COPD Exacerbations: Results from a Prospective Study Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019